PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF UPADACITINIB IN CHILDREN WITH ATOPIC DERMATITIS

被引：0
|
作者：
Qian, Y. [1 ]
Raymundo, E. [1 ]
Hao, S. [1 ]
Unnebrink, K. [2 ]
Liu, J. [1 ]
Teixeira, H. [1 ]
Chu, A. [1 ]
Paller, A. [3 ]
Liu, W. [1 ]
Mohamed, M. [1 ]
机构：
[1] AbbVie, N Chicago, IL USA
[2] AbbVie DeutschIand GmbH & Co KG, Ludwigshafen, Germany
[3] Northwestern Univ, Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-114
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis
    Zhang, Libo
    Zhang, Weilong
    Xu, Yufeng
    Dong, Lihou
    Sun, Yunjuan
    Jia, Yingmin
    Li, Zhichuan
    Chen, Bo
    Hou, Jie
    Zhang, Jianzhong
    ADVANCES IN THERAPY, 2024, : 2953 - 2965
  • [2] Pharmacokinetics, Safety, and Tolerability of Tezepelumab (AMG 157) in Healthy and Atopic Dermatitis Adult Subjects
    Parnes, Jane R.
    Sullivan, John T.
    Chen, Li
    Dias, Clapton
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (02) : 441 - 449
  • [3] Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis
    Leung, Donald Y. M.
    Paller, Amy S.
    Zaenglein, Andrea L.
    Tom, Wynnis L.
    Ong, Peck Y.
    Venturanza, May E.
    Kuligowski, Michael E.
    Li, Qian
    Gong, Xiaohua
    Lee, Mark S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (04) : 500 - +
  • [4] Upadacitinib for Patients with Atopic Dermatitis
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (09) : 506 - 506
  • [5] Upadacitinib for moderate to severe atopic dermatitis
    Navarro-Trivino, Francisco
    Alcantara-Luna, Sara
    Dominguez-Cruz, Javier
    Galan-Gutierrez, Manuel
    Ruiz-Villaverde, Ricardo
    Pereyra-Rodriguez, Jose-Juan
    Armario-Hita, Jose-Carlos
    IMMUNOTHERAPY, 2023, 15 (11) : 799 - 808
  • [6] Safety, tolerability, and pharmacokinetics of remacemide in children
    Besag, FMC
    Newton, RE
    Blakey, GE
    Dean, ADP
    PEDIATRIC NEUROLOGY, 2001, 24 (05) : 352 - 356
  • [7] Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting
    Patruno, Cataldo
    Lauletta, Giuseppe
    Pezzolo, Elena
    Boccaletti, Valeria
    Rossi, Mariateresa
    Caroppo, Francesca
    Fortina, Anna Belloni
    Russo, Filomena
    Cocuroccia, Barbara
    Dal Bello, Giacomo
    Martora, Fabrizio
    di Vico, Francesca
    Napolitano, Maddalena
    CLINICAL DRUG INVESTIGATION, 2024, 44 (08) : 629 - 634
  • [8] Effectiveness and safety of upadacitinib in patients with face and neck atopic dermatitis unresponsive to dupilumab
    Yang, Yan
    Chen, Jiaoquan
    Yu, Nanji
    Ke, Yanan
    Gao, Aili
    Xiong, Siying
    Zhao, Xiaolan
    Liu, Yumei
    Zhu, Huilan
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [9] The Usefulness of Atopic Dermatitis Control Tool in Upadacitinib Treatment for Patients with Atopic Dermatitis
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    DERMATOLOGIC THERAPY, 2024, 2024
  • [10] Response to upadacitinib in a patient with atopic dermatitis and HIV
    Riquelme-Mc Loughlin, Constanza
    Sanchez-Palomino, Sonsoles
    Blanco, Jose L.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
12345